http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8#head http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8 http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8#assertion http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8 http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8#provenance http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8 http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8#publicationInfo http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8#assertion http://bio2rdf.org/drugbank:DB00872 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00872_DB04946 http://bio2rdf.org/drugbank:DB04946 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00872_DB04946 http://bio2rdf.org/drugbank_resource:DB00872_DB04946 http://purl.org/dc/terms/identifier drugbank_resource:DB00872_DB04946 http://bio2rdf.org/drugbank_resource:DB00872_DB04946 http://purl.org/dc/terms/title DDI between Conivaptan and Iloperidone - CYP3A4 Inhibitors (Strong) may increase serum concentrations of the active metabolite(s) of Iloperidone. Specifically, concentrations of the metabolites P88 and P95 may be increased. CYP3A4 Inhibitors (Strong) may increase the serum concentration of Iloperidone. Reduce iloperidone dose by half when administered with a strong CYP3A4 inhibitor. http://bio2rdf.org/drugbank_resource:DB00872_DB04946 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00872_DB04946 http://www.w3.org/2000/01/rdf-schema#label DDI between Conivaptan and Iloperidone - CYP3A4 Inhibitors (Strong) may increase serum concentrations of the active metabolite(s) of Iloperidone. Specifically, concentrations of the metabolites P88 and P95 may be increased. CYP3A4 Inhibitors (Strong) may increase the serum concentration of Iloperidone. Reduce iloperidone dose by half when administered with a strong CYP3A4 inhibitor. [drugbank_resource:DB00872_DB04946] http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8#provenance http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8#publicationInfo http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8#signature.MCwCFDqAKVCfaqzb http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8#signature.MCwCFDqAKVCfaqzb http://purl.org/nanopub/x/hasSignature MCwCFDqAKVCfaqzbs2H4f0GjFi4hmS31AhQpK1E+O4XAw1g3XVy5ZzARO+naTQ== http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8#signature.MCwCFDqAKVCfaqzb http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8 http://purl.org/dc/terms/created 2018-03-30T11:12:46.662+02:00 http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8 http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8 http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8#signature.MCwCFDqAKVCfaqzb http://bio2rdf.org/drugbank_resource:DB00872_DB04946_nanopub.RAW3ABk8OlLczl1eE1LqAg_nkOrMCRA_naENpo_uOWhN8 http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234